健麾信息最新公告：拟7371万元收购AI应用公司博科国信38%股权

Group 1 - The company plans to acquire equity stakes in Boke Guoxin (Wuhan) Technology Co., Ltd. for a total of 10,371.02 million yuan, which includes 3,768.75 million yuan from Zhou Xiaoping, 2,285.63 million yuan from Ze Pu Investment, 637.50 million yuan from Boke Yixin, and 679.14 million yuan from Boke Guoxin [1] - After the completion of the transaction, the company will hold 70% of the equity in the target company [1] - The target company is a member of the China Medical Health Information Interconnection Technology Alliance and HL7 China, and is the first medical information technology enterprise in Central China to pass 13 system tests of FHIR Connectathon [1] Group 2 - The target company's research and development in medical AI applications, such as the B-Klinik intelligent agent, will inject innovative momentum into the company's core business [1] - This acquisition is expected to help the company explore business opportunities in smart hospitals, county-level medical communities, and digital health management [1]